Transcript
Our next topic is the use of psychotropic drugs in gastrointestinal diseases.
Patients whose gastrointestinal disease results in chronic malabsorption such as pancreatitis, inflammatory bowel disease, patients with gastric bypass predictably are going to have some difficulties in absorbing most psychotropic drugs.Patients with delayed gastric emptying like patients with diabetic gastroparesis are going to be more subject to worsening of their medical condition if they’re given an anticholinergic drug and may have difficulty absorbing some psychotropic drugs because of increased exposure to gastric acid in a gastroparetic patient. In patients with gastrointestinal problems causing constipation, of course we should avoid anticholinergic drugs.
References
- Levenson, J. L., & Ferrando, S. J. (Eds.). (2016). Clinical manual of psychopharmacology in the medically ill . American Psychiatric Pub.
- Ruepert, L., Quartero, A et al (2011). Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome . The Cochrane Library.
- Rahimi R et al. World J Gastroenterol. 2009 ;15:1548-53. , Trinkley & Nahata.J Clin Pharm Ther. 2011;36:275-82., Enck et al Eur J Gastroenterol Hepatol.2010;22:1402-11.,
- Remes-Troche et al.Rev Gastroenterol Mex.2010;75:42-66. , Chao & Zhang. Intern Med.2013;52:419, Ford et al.Am J Gastroenterol.2014 ;109:1350
- Pace, F., Maurano, A., Ciacci, C.et el (2010). Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial . Eur Rev Med Pharmacol Sci, 14(3), 155-162.
- Lewis-Fernández, R.,et al (2016). An open-label pilot study of duloxetine in patients with irritable bowel syndrome and comorbid major depressive disorder . Journal of clinical psychopharmacology, 36(6), 710-715.
- Marzinke Ther Drug Monit.2015;37:408-12, Hamad GG, Am J Psychiatry 2012;169:256-63 , Roerig JL, Surg Obes Relat Dis.2012;8:62-6, Roerig et al. J Clin Psychopharmacol. 2013;33:479
- J Clin Psychopharmacol. 2011;31:261-2, Case Rep.2016 Mar 18;2016
- Pharmacotherapy.2015;35:361-9
